Analysis Of Income And Expense [Abstract]

Optomed Oyj - Filing #3684582

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue
15 040 EUR
15 100 EUR
Material income and expense [abstract]
Finance income (cost)
441,000 EUR
545,000 EUR
Expenses by nature [abstract]
Classes of employee benefits expense [abstract]
Employee benefits expense
8 931 EUR
8 699 EUR
Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract]
Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss
2 499 EUR
2 193 EUR
Other expenses, by nature
4 204 EUR
3 374 EUR
Miscellaneous other comprehensive income [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations and hedges of net investments in foreign operations [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations
329,000 EUR
329,000 EUR
283,000 EUR
283,000 EUR
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income
5 778 EUR
329,000 EUR
5 450 EUR
4 157 EUR
4 441 EUR
283,000 EUR
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent
5 778 EUR
4 157 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.